ResearcherUniversity of Southern DenmarkNo recent work listed

Malene Nielsen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-3084-7522; OpenAlex author ID A5101030375. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2021: 1 paper

Papers 1

Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated with PIPAC. Co-author DOI 10.1136/jclinpath-2020-206607 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Martin Graversen · 1 shared paper, 2021 · strength 0.14
- Paper Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated… DOI 10.1136/jclinpath-2020-206607 ↗
Claus Wilki Fristrup · 1 shared paper, 2021 · strength 0.14
- Paper Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated… DOI 10.1136/jclinpath-2020-206607 ↗
Per Pfeiffer · 1 shared paper, 2021 · strength 0.14
- Paper Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated… DOI 10.1136/jclinpath-2020-206607 ↗
Michael Bau Mortensen · 1 shared paper, 2021 · strength 0.14
- Paper Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated… DOI 10.1136/jclinpath-2020-206607 ↗
Sönke Detlefsen · 1 shared paper, 2021 · strength 0.14
- Paper Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated… DOI 10.1136/jclinpath-2020-206607 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.